With the analysis among 1,372 patents, we discovered top 453 key players by total patent application. Yamanouchi Pharmaceutical Co., Ltd., Astellas Pharma, Inc., Eli Lilly & Co. are dominant in this area. They take 5.98% of the total patent filing.
Yamanouchi Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 34
Tokyo-to, Japan
Patent: 25
Indiana, United States
Patent: 23
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 21
Aragon Pharmaceuticals, Inc.
California, United States
Patent: 18
Tokyo-to, Japan
Patent: 17
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 14
New Jersey, United States
Patent: 12
With the analysis among 39 patents, we discovered top 13 start-ups by total patent application. Urotronic, Inc., Deepbio Co., Ltd., Nanostics, Inc. are active in this area.
Minnesota, United States
Patent: 9
Institut National de la Santé et de la Recherche Médicale
Alessa Therapeutics, Inc.
California, United States
Patent: 3
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 2
Enliven Therapeutics, Inc. /US/
Colorado, United States
Patent: 1
Beijing Xiangxin Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Massachusetts, United States
Patent: 1
With the analysis among related 940 patents applied in the last 5 years. We discover 492 most active companies in this area. The fast-growing Hinova Pharmaceuticals, Inc., TRON - Translationale Onkologie an der Universitätsmedizin der, BioNTech SE take 4.04% of patent filing during this period.
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 14
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 13
Rheinland-Pfalz, Germany
Patent: 11
Regents of the University of California
California, United States
Patent: 11
BIOLAB SANUS Farmacêutica Ltda.
São Paulo, Brazil
Patent: 11
Aragon Pharmaceuticals, Inc.
California, United States
Patent: 9
Hexamer Therapeutics, Inc.
Washington, United States
Patent: 8
University of Tennessee Research Foundation
Tennessee, United States
Patent: 7
With the analysis among related 940 patents in last 5 years, we discover 392 new entrants. Hinova Pharmaceuticals, Inc., TRON - Translationale Onkologie an der Universitätsmedizin der, BioNTech SE are the most active new entrants in this area.
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 14
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 13
Rheinland-Pfalz, Germany
Patent: 11
BIOLAB SANUS Farmacêutica Ltda.
São Paulo, Brazil
Patent: 11
Hexamer Therapeutics, Inc.
Washington, United States
Patent: 8
Allife Medicine (Zhuhai Hengqin New Area) Co., Ltd.
Progenics Pharmaceuticals, Inc.
New York, United States
Patent: 6
With the analysis among 652 patents, we discovered top 200 universities and scientific research institutions by total patent application. Zhejiang University, Fudan University, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 9.20% of the total patent filing.
Zhejiang Sheng, China
Patent: 17
Shanghai Shi, China
Patent: 15
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 14
University of British Columbia
British Columbia, Canada
Patent: 13
Zhejiang Ocean University
Zhejiang Sheng, China
Patent: 13
The Johns Hopkins University
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 10
Guangdong University of Technology
Guangdong Sheng, China
Patent: 10
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 9
Sichuan Sheng, China
Patent: 8